AFT PHARMACEUTICALS

AFT
End-of-day quote. End-of-day quote  - 11/26
4.8NZD +2.13%

AFT Pharmaceuticals : ASM resultsOpens in a new Window

09/08/2020 | 12:30am

8 September 2020

Results of 2020 Annual Shareholder Meeting

At AFT Pharmaceuticals Limited's (NZX: AFT / ASX: AFP) annual shareholder meeting held virtually today, shareholders were asked to vote on two resolutions, both of which were supported by the Board.

As required by NZX Listing Rule 6.1, all voting was conducted by a poll.

The resolutions passed by shareholders were:

1. That the directors are authorised to fix the fees and expenses of Deloitte as auditor for the 2021 financial year.

2.

That Ms Marree Atkinson be re-elected as a director of AFT Pharmaceuticals Limited.

Detail of the total number of votes cast in person or by a proxy holder are:

Resolution

For

Against

Abstain

1.

That the directors are authorised to fix the fees and expenses of Deloitte as auditor for the 2021 financial year.

87,540,520 99.99%

11,972 0.01%

2,000

2.

That Ms Marree Atkinson be re-elected as a director of AFT Pharmaceuticals Limited.

87,552,227 100.00%

1,145 0.00%

120

Authority for this announcement

Name of person authorised to make this announcement

Malcolm Tubby, Chief Financial Officer

Contact person for this announcement

Malcolm Tubby

Contact phone number

+64 9 488 0232

Contact email address

Investor.relations@aftpharm.com

Date of release through MAP

8 September 2020

Page 1 of 1

This is an excerpt of the original content. To continue reading it, access the original document here.

Disclaimer

AFT Pharmaceuticals Limited published this content on 08 September 2020 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 08 September 2020 04:29:03 UTC

© Publicnow 2020
Copier lien
All news about AFT PHARMACEUTICALS LIMITED
7d ago
7d ago
11/18
11/17
11/09